Insider · CIK 0001698838
Jerome D Jabbour
Files at MTNB (Matinas BioPharma Holdings, Inc.), INDP (Indaptus Therapeutics, Inc.). First filing -, latest -.
Jerome D Jabbour files SEC Form 4 as CEO, president and director at MTNB (Matinas BioPharma Holdings, Inc.), and also at INDP (Indaptus Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jerome D Jabbour has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | INDP Indaptus Therapeutics, Inc. | AGrant or award Option to Buy Common Stockderivative | +25,000 | $0.00 | $0 | 25,000 | Feb 27, 2026 |
| Apr 30, 2025 | MTNB Matinas BioPharma Holdings, Inc. | AGrant or award Stock Option (right to Buy)derivative | +70,100 | $0.00 | $0 | 70,100 | May 2, 2025 |
Questions about Jerome D Jabbour
Answered from the filings on this page, as of the latest one.
Is Jerome D Jabbour buying or selling?
Jerome D Jabbour has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jerome D Jabbour's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jerome D Jabbour has 0.
Where does Jerome D Jabbour file Form 4?
Jerome D Jabbour has filed Form 4 at MTNB (Matinas BioPharma Holdings, Inc.) as President and CEO; INDP (Indaptus Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.